EZRA Innovations' Unattributed - II Round

EZRA Innovations raised a round of funding on October 28, 2016.

EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical i…

Articles about EZRA Innovations' Unattributed - II Round: